Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-05-12 16:05:17 ET · period of report 2026-05-11 · accession 0001185945-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-12 16:05 | 2026-05-11 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.44 | +14.3K | 71.4K | +25% | +$35.0K |
| DT | 2026-05-12 16:05 | 2026-05-11 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $7.04 | -8,346 | 63.1K | -12% | -$58.8K |
| DT | 2026-05-12 16:05 | 2026-05-11 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.44 | -14.3K | 186.2K | -7% | -$35.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-05-11 | M | A | 14,344 | $2.44 | 71,423 | D | — | — | (F1) Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on May 19, 2025. |
| 2 | Common | Common Shares | 2026-05-11 | S | D | 8,346 | $7.04 | 63,077 | D | — | — | (F2) Shares sold to satisfy tax obligation on option exercise. |
| 3 | Derivative | Stock Option | 2026-05-11 | M | D | 14,344 | $2.44 | 186,189 | D | $2.44 · 2016-06-09 to 2026-06-09 | 14,344 Common shares | (F3) Represents options exercised pursuant to a 10b5-1 plan adopted on May 19, 2025. |